UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000037709
Receipt No. R000042960
Scientific Title The offect of Aromatherapy massage for the patients with Schizophrenia
Date of disclosure of the study information 2019/08/18
Last modified on 2019/08/17 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The offect of Aromatherapy massage for the patients with Schizophrenia
Acronym The offect of Aromatherapy massage for the patients with Schizophrenia
Scientific Title The offect of Aromatherapy massage for the patients with Schizophrenia
Scientific Title:Acronym The offect of Aromatherapy massage for the patients with Schizophrenia
Region
Japan

Condition
Condition Schizophrenia
Classification by specialty
Psychiatry Nursing
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To reveal the Aromatherapy massage for the patients with Schizophrenia
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Scale of feeling of relaxation
Salivary amylase
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Aromatherapy massage
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patients with Schizophrenia during hospitalization
Key exclusion criteria The people with Allergic reaction by patch test
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Taeko
Middle name
Last name Kumazawa
Organization National Hospital Organization Simofusa Psychiatric hospital
Division name Nursing division
Zip code 266-0007
Address 578 , Hetacho , Midori-ku , Chiba-si , Chiba
TEL 043-291-1221
Email kumazawa.taeko.mg@mail.hosp.go.jp

Public contact
Name of contact person
1st name Taeko
Middle name
Last name Kumazawa
Organization National Hospital Organization Simofusa Psychiatric hospital
Division name Nursing division
Zip code 266-0007
Address 578 , Hetacho , Midori-ku , Chiba-si , Chiba
TEL 043-291-1221
Homepage URL
Email kumazawa.taeko.mg@mail.hosp.go.jp

Sponsor
Institute National Hospital Organization Simofusa Psychiatric hospital
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization National Hospital Organization Simofusa Psychiatric hospital
Address 578 , Hetacho , Midori-ku , Chiba-si , Chiba
Tel 043-291-1221
Email kumazawa.taeko.mg@mail.hosp.go.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 独立行政法人国立病院機構下総精神医療センター(千葉県)

Other administrative information
Date of disclosure of the study information
2019 Year 08 Month 18 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
2020 Year 03 Month 31 Day
Baseline Characteristics
Schizophrenia
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2019 Year 08 Month 13 Day
Date of IRB
Anticipated trial start date
2019 Year 08 Month 13 Day
Last follow-up date
2020 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 08 Month 17 Day
Last modified on
2019 Year 08 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042960